Arthritis and X-linked agammaglobulinemia by Machado, P et al.
ÓRGÃO OF IC IAL DA SOC IEDADE PORTUGUESA DE REUMATOLOGIA - ACTA REUMATOL PORT. 2008;33:464-72
464
C A S O C L Í N I C O
A R T H R I T I S A N D X - L I N K E D
A G A M M A G L O B U L I N E M I A
Pedro Machado,*§ Alexandra Santos,**§ Emília Faria,** Jorge Silva,* Armando Malcata,* Celso Chieira**
defeitos quantitativos e/ou funcionais genetica-
mente determinados, em um ou mais componen-
tes do sistema imunitário. Imunodeficiência e ar-
trite podem estar relacionadas, mas os mecanis-
mos que as relacionam nem sempre são claros. Di-
ferentes causas de imunodeficiência podem surgir
secundariamente em doentes com artrite; por ou-
tro lado, a artrite pode ser uma manifestação de
imunodeficiência primária. A artrite ocorre predo-
minantemente em doentes com imunodeficiên-
cias humorais, nomeadamente na agamaglobuli-
némia ligada ao X e na imunodeficiência comum
variável, e pode ser um dos sinais de alarme para
imunodeficiência primária. Os autores apresentam
um caso em que a artrite fez parte do quadro de
apresentação da agamaglobulinémia ligada ao X.
Nesta imunodeficiência, a artrite pode ser conse-
quência de infecção, particularmente por Myco-
plasma, ou da própria disfunção imunitária. Em
crianças e ocasionalmente em adultos jovens, a
conjugação de artrite com hipogamaglobulinémia
deve sugerir imunodeficiência primária, sem des-
curar a exclusão de outras causas de hipogamaglo-
bulinémia. Os médicos envolvidos na avaliação de
doentes com artrite devem estar cientes desta pos-
sibilidade, de modo a assegurarem um diagnósti-
co precoce, um objectivo primordial para a optimi-
zação terapêutica e prognóstico destes doentes.
Palavras-chave:Artrite; Agamaglobulinémia Liga-
da ao X; Hipogamaglobulinémia; Imunodeficiência
primária; Imunoglobulina
Introduction
Primary immunodeficiencies (PIDs) are defined as
genetically determined functional and/or quanti-
tative abnormalities in one or more of the immu-
ne system components. Immunodeficiency and
arthritis can be related, although the mechanisms
are not always clear. Different causes for immuno-
deficiency can secondarily be found in patients
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Abstract
Primary immunodeficiencies are defined as geneti-
cally determined functional and/or quantitative
abnormalities in one or more of the components of
the immune system. Immunodeficiency and arthri-
tis can be related, although the mechanisms are not
always clear. Different causes for immunodeficiency
can secondarily be found in patients with arthritis;
on the other hand, arthritis can be a manifestation
of primary immunodeficiency. Arthritis occurs
chiefly in humoral primary immunodeficiencies, na-
mely in X-linked agammaglobulinemia and com-
mon variable immunodeficiency, and may be one of
the warning signs for primary immunodeficiency.
We report a case of arthritis as the presenting featu-
re of X-linked agammaglobulinemia. In X-linked
agammaglobulinemia, arthritis may be a conse-
quence of infection, most notably by Mycoplasma,
or of immune dysfunction itself. In children, and oc-
casionally in young adults, a combination of arthri-
tis and hypogammaglobulinemia should suggest
primary immunodeficiency, although other causes
of hypogammaglobulinemia must be excluded.
Physicians evaluating patients with arthritis should
be aware of this fact so that an early diagnosis can
be pursued as it is of extreme importance in the opti-
mal management and prognosis of these patients.
Keywords: Arthritis; X-linked Agammaglobuline-
mia; Hypogammaglobulinemia; Primary Immuno-
deficiency; Immunoglobulin
Resumo 
As imunodeficiências primárias definem-se como
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with arthritis; on the other hand, arthritis can be a
manifestation of PID. 
Arthritis occurs chiefly in humoral PID, namely
in X-linked agammaglobulinemia (XLA) and com-
mon variable immunodeficiency, and may be one
of the warning signs for primary immunodefi-
ciency. Indeed, Bruton1 first described XLA in a pa-
tient with arthritis. In this paper, we report a case
of arthritis in a patient with XLA, and discuss it re-
garding the literature about the relationship bet-
ween arthritis and PIDs.
Case Report
A white male, currently 30 years old, presented at
the age of 3 years with arthritis of the right knee and
left ankle (Figures 1, 2 and 3). Right thigh and leg
wasting were already evident when the child was
observed, 11 months after the first episode of
arthritis. He had a history of recurrent upper respi-
ratory tract infections, conjunctivitis and gastro-
enteritis (including Giardia lamblia and Salmonel-
la), and bronchopneumonia requiring hospital ad-
mission at the age of 4 months. He had been repe-
atedly given antibiotics, often during long periods
of time.
The child’s growth and psychomotor develop-
ment were normal. His non-consanguineous pa-
rents and paternal half-brother were healthy. A ma-
ternal uncle had died of pneumonia at the age of 9.
Initial investigations at the age of 3 years revea-
led normal blood cell count (including total lym-
phocyte count), normal urinalysis and erythrocyte
sedimentation rate, increased C-reactive protein
and severe hypogammaglobulinemia with low le-
vels of all immunoglobulin isotypes (IgG 0.5 g/L,
IgM 0.4 g/L, IgA<0.07 g/L and IgE<18 UI/mL).
Rheumatoid factor was absent.
A humoral primary immunodeficiency was the
probable diagnosis and treatment was initiated at
the age of 4 years with weekly intramuscular (IM)
immunoglobulin (later fortnightly), acetylsalicylic
acid (later naproxen) and physiotherapy. At that
time (about 30 years ago) IM immunoglobulin was
the only one available, intravenous (IV) immuno-
globulin only becoming available about 10 years
later.
Additional evaluation later performed revealed
1% of CD19+ cells, normal complement levels and
negative assays for nuclear autoantibodies. More
recently, molecular analysis confirmed the diagno-
Figure 1, 2 and 3. Arthritis of the right knee and left ankle
at the age of 3. Right tight and leg wasting are also visible.
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sis of XLA, showing a nonsense BTK mutation
(R255X).
Several complications were observed during
childhood: gastroenteritis, conjunctivitis, adenoi-
ditis, pharingitis, sinusitis, bronquitis and suppu-
rated otitis media with perforation (without hea-
ring loss). Multiple antibiotics were given. An im-
provement in the frequency and severity of the
infectious episodes was noticed with immunoglo-
bulin replacement.
Left ankle arthritis resolved after initiating im-
munoglobulin therapy, but right knee arthritis be-
came relapsing until the age of 8, responding to
higher doses of IM immunoglobulin given during
arthritis flares. Left knee arthritis was observed at
the age of 10 and 15, again responding to higher do-
ses of IM immunoglobulin. The boy also developed
a 4 cm inferior limb dysmetry (Figure 4) compen-
sated with heal on left shoe. 
Since the age of 16, he has been given IV immu-
noglobulin (Octagam®, 400-600 mg/Kg, every three
to four weeks, aiming at serum IgG levels above
6g/L), with significant improvement of the serum
immunoglobulin levels. Infections became less fre-
quent and severe, and antibiotics-free periods be-
came longer after starting IV immunoglobulin. Hig-
her doses have been given at the age of 23, when he
had a prolonged episode of arthritis (see below). He
has recently initiated subcutaneous immunoglo-
bulin (Gammanorm®, 100 mg/Kg, weekly), with a
positive impact on his quality of life and more sta-
ble serum IgG levels. Chronic sinusitis, chronic
mastoiditis and bilateral bronchiectasis (cylindri-
cal and sacular, predominantly in the lower lobes
and on the right) have been observed as additional
complications of the disease.
At the age of 23, he had the last episode of arthri-
tis, with the left knee being affected. Initially, it did
not resolve with an increase in IV immunoglobulin
dose (800mg/Kg every three to four weeks) and fur-
ther investigation was undertaken. Synovial fluid
analysis revealed an aseptic inflammatory fluid wi-
thout crystals: the fluid was yellow and translucent
with a white blood cell count of 41400/mm3 and
88% polymorphonuclear leukocytes; gram stain
and cultures (including Mycobacterium) were ne-
gative and crystals were absent. Magnetic resonan-
ce imaging showed a minor subcondral sclerosis of
the lateral tibial plate and marginal osteophytosis
of tibial spines; there was a large intra-articular ef-
fusion and extended synovitis; the nodular and po-
lilobulated hypointense appearance of the syno-
vial raised the hypothesis of pigmented villonodu-
lar synovitis. Biopsy was performed (Figure 5) reve-
aling synovial hyperplasia and capillary
Figure 5. Left knee synovial biopsy at the age of 23,
showing hyperplasia and capillary proliferation 
predominantly with neutrophilic infiltrate (stain,
hematoxylin and eosin; original magnification, x400).
Figure 4. Inferior limb dysmetry (4 cm) on metric 
radiography at the age of 10
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proliferation predominantly with neutrophilic in-
filtrate. Arthritis progressively resolved over a six-
month period of high doses of IV immunoglobu-
lin (800mg/Kg every three to four weeks), aiming
at serum immunoglobulin levels above 8g/L. No
further episodes of arthritis have occurred so far.
Discussion
XLA is a PID caused by mutations in the Bruton
tyrosine kinase (BTK) gene, which is essential for
B-cell development and proliferation.2 Affected in-
dividuals have hypogammaglobulinemia, marked-
ly reduced levels of serum antibodies and marked-
ly reduced levels of B cells.
Clinical symptoms usually start after the age of
6 months, once maternal antibodies disappear
from the infant’s blood stream, and mainly consist
of recurrent respiratory and gastrointestinal infec-
tions. The microorganisms most commonly impli-
cated3 are encapsulated bacteria (e.g. Streptococ-
cus, Haemophilus influenza, Staphylococcus au-
reus and Pseudomonas) affecting the respiratory
tract, skin, bone, joints and central nervous system.
The anti-viral immunity is generally preserved, ex-
cept for Enterovirus (Poliovirus,Echovirus and Cox-
sackievirus) which may cause central nervous sys-
tem infection. In the gastrointestinal tract, apart
from gastroenteritis (Giardia, Campylobacter and
Salmonella are common bacterial agents and Ro-
tavirus and Enterovirus are common viral agents),
inflammatory bowel disease mimicking Chron’s di-
sease may occur. Other manifestations can be
arthritis, osteomyelitis, sepsis, and more rare disor-
ders such as hepatitis, vaccine-related polio, wild
polio, hand-foot-and-mouth disease and neutro-
penia.3 The criteria for the diagnosis of XLA were
established by the European Society for Primary
Immunodeficiencies and are listed in Table I. Dif-
ferential diagnosis of hypogammaglobulinemia
are presented in Table II.
In the case we describe, the child’s growth and
psychomotor development were normal. Although
infections were frequent, they were considered to
be mild to moderate in severity, except for one epi-
sode of infection in which hospitalization was re-
quired. These two factors probably contributed to
a delay in diagnosis and emphasise the need of a
high index of suspicion for the disease. In a cohort
of 201 patients from the United States of America,3
only about half of the patients were diagnosed with
agammaglobulinemia/hypogammaglobulinemia
by 2 years of age, and about 20% were still undiag-
nosed by school age. A few patients were not diag-
nosed until adolescence or adulthood, some in spi-
te of a positive family history at the time of their
birth. Other authors have reported families in
which affected individuals have not been diagno-
sed with an immunodeficiency until adulthood,
some of whom had relatively mild symptoms
and/or late onset of symptoms,4-6 highlighting the
need for a high index of suspicion and that al-
though gene defects are known, there are no ge-
Table I. Diagnostic criteria of X-linked agammaglobulinemia
Definitive:
– Male patient with less than 2% CD19+ B cells and at least one of the following:
1) Mutation in Btk, 2) Absent Btk mRNA on northern blot analysis of neutrophils or monocytes, 3) Absent Btk
protein in monocytes or platelets, 4) Maternal cousins, uncles or nephews with less than 2% CD19+ B cells
Probable:
– Male patient with less than 2% CD19+ B cells in whom all of the following are positive:
1) Onset of recurrent bacterial infections in the first 5 years of life, 2) Serum IgG, IgM and IgA more than 2SD
below normal for age, 3) Absent isohemagglutinins and /or poor response to vaccines, 4) Other causes of
hypogammaglobulinemia have been excluded (see Table II)
Possible:
– Male patient with less than 2% CD19+ B cells in whom other causes of hypogammaglobulinemia have been
excluded (see Table II) and at least one of the following is positive:
1) Onset of recurrent bacterial infections in the first 5 years of life, 2) Serum IgG, IgM and IgA more than 2 SD
below normal for age, 3) Absent isohemagglutinins
Source: European Society for Immunodeficiencies. http://www.esid.org/workingparty.php?party=3&sub=2&id=73.Acceded 24 April 2008.
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notype-phenotype associations.
Janeway7 back in 1956 found an increased inci-
dence of arthritis, with negative joint fluid cultu-
res, in children with XLA. Later, it was found that
some of these patients may have arthritis due to
Mycoplasma infections, although in many cases
no pathogen could be identified in the joint fluid.8
Patients with humoral PIDs are more prone to
arthritis, most notably XLA, common variable im-
munodeficiency9 (CVID), hyper-IgM syndromes,10
and IgA deficiency.11 A few cases of arthritis have
been reported in patients with chronic granuloma-
tous disease,12 Wiskott-Aldrich syndrome,13 inter-
leukin-1 receptor-associated kinase-4 deficiency14,15
(a more recently described immunodeficiency af-
fecting the toll-like receptor pathways) and cellu-
lar or combined immunodeficiency syndromes.11 In
patients with humoral PID, the prevalence of joint
manifestations before treatment has ranged from
5% to 40% in different studies.11
Hansel et al16 identified seven cases of mono-
arthritis and one case of oligoarthritis among 69
patients with agammaglobulinemia, as well as one
case of monoarthritis and seven cases of oligo-
arthritis among 161 patients with CVID. Impor-
tantly, arthritis can reveal PID in children and is oc-
casionally the presenting symptom of CVID in
adults. Incontrovertible evidence of infection is
found in some cases, whereas in others an immu-
ne dysregulation-related synovial disorder seems
to be involved.
Our patient presented at the age of 3 with chro-
nic asymmetric oligoarthritis and a history of re-
lapsing episodes of arthritis until the age of 23,
when he developed a persistent episode of mono-
arthritis.
About 10–30% of arthritis cases in patients with
humoral PIDs seem aseptic.17 Similarly to our pa-
tient, it has been reported that aseptic arthritis may
be more common among children and males, most
notably those with agammaglobulinemia or pro-
found hypogammaglobulinemia.17 Contrary to our
patient, polyarthritis has been described by some
as the most common pattern in aseptic arthritis.
Studies of affected families found no increase in
the rate of joint manifestations among immuno-
competent first-degree relatives, a finding that sug-
gests the direct link between apparently aseptic
arthritis and decreased immunoglobulin levels.18
Therefore, the history of chronic asymmetric oli-
goarthritis in a young child with hypogammaglo-
bulinemia seems more likely related to an immu-
ne dysregulation-related synovial disorder, as does
the history of relapsing episodes of arthritis until
the age of 23. This is further supported by the good
response to increasing doses of immunoglobulin.19
The absence of rheumatoid factor and anti-nu-
clear autoantibodies is typical of patients with hu-
moral PID because of decreased immunoglobulin
synthesis. Noticeable, classical rheumatoid arthri-
tis may occur in hypogammaglobulinemia, but is
uncommon and rheumatoid factor is absent. In an
Table II. Differential diagnosis of hypogammaglobulinemia
Drug Induced:
Antimalarial agents, Captopril, Carbamazepine, Glucocorticoids, Fenclofenac, Gold salts, Penicillamine, Phenytoin,
Sulfasalazine
Genetic Disorders:
Ataxia Telangiectasia,Autosomal forms of SCID, Hyper IgM Immunodeficiency,Transcobalamin II deficiency and
hypogammaglobulinemia, X-linked agammaglobulinemia, X-linked lymphoproliferative disorder (EBV associated),
X-linked SCID, Some metabolic disorders, Chromosomal Anomalies, Chromosome 18q- Syndrome, Monosomy 22,
Trisomy 8,Trisomy 21
Infectious Diseases:
HIV, Congenital Rubella, Congenital infection with CMV, Congenital infection with Toxoplasma gondii, Epstein-Barr Virus
Malignancy:
Chronic Lymphocytic Leukemia, Immunodeficiency with Thymoma, Non Hodgkin's lymphoma, B cell malignancy
Systemic Disorders:
Immunodeficiency caused by hypercatabolism of immunoglobulin, Immunodeficiency caused by excessive loss of
immunoglobulins (nephrosis, severe burns, lymphangiectasia, severe diarrhea)
Source: European Society for Immunodeficiencies. http://www.esid.org/workingparty.php?party=3&sub=2&id=73.Acceded 24 April 2008.
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analysis of 248 patients with CVID, five patients
had concurrent rheumatoid arthritis and four had
polyarticular juvenile idiopathic arthritis.9,20 Clas-
sical RA is even more uncommon in XLA,21,22 a si-
tuation that has attracted attention as B-cell deple-
tion by rituximab leads to improvement in RA in
immunocompetent individuals.23
Persistent monoarthritis at the age of 23 not
responding to high doses of immunoglobulin was
particularly worrisome. Infection or a coexisting
local or systemic disease had to be thoroughly in-
vestigated. Joint infection has always to be beard
in mind in a patient with humoral PID and arthri-
tis. The likelihood of septic arthritis is greatest in
patients with monoarthritis, as was the case of our
patient at the age of 23, with only one affected joint.
Pyogenic bacteria account for most cases (Staphy-
lococcus aureus, Streptococcus pneumoniae, and
Haemophilus influenzae). The profound IgG defi-
ciency found in many patients with PID results in
considerable vulnerability to encapsulated orga-
nisms. Viral arthritis is uncommon, the main cau-
ses being adenovirus type I and echovirus 11.24-27
Mycoplasma is a major cause of arthritis in patients
with humoral PID and Ureaplasma urealyticum
has been the most commonly recovered mycoplas-
mal agent, although M. pneumoniae, M. hominis,
and M. salivarium have also been incrimina-
ted.11,28,29 In a study of patients with hypogamma-
globulinemia, Furr et al29 found a 38% rate of Myco-
plasma-positive cultures from joints with arthritis. 
The mechanisms underlying the link between
humoral PID and mycoplasmal arthritis are un-
clear. Increased susceptibility to mucosal coloni-
zation with mycoplasmas in patients with hypo-
gammaglobulinemia has been demonstrated29 and
might be explained by the lack of protective anti-
bodies at mucosal surfaces. The possibility of hi-
gher mucosal colonization in patients lacking suf-
ficient antibodies may also account for the increa-
sed risk of dissemination from the respiratory and
urogenital tracts to the joints and other distant si-
tes in these patients. It is not fully understood why
Mycoplasma species have a tendency to infect the
joints of these patients. In vitro work has sugges-
ted that minor trauma common to large joints at-
tracts neutrophils and neutrophils have been
shown to take up mycoplasmas into phagocytic
vacuoles in the absence of specific antibodies whe-
re they remain viable and are subsequently relea-
sed into joint spaces.30 Additionally, synovial fluid
is presumed to be a favourable environment in
which mycoplasmas can grow. 
In the case we report, at the age of 23, no micro-
organisms were identified in synovial fluid, when
analysis was performed for persistent monoarthri-
tis. By definition, in immune dysregulation-related
arthritis, the synovial specimens are negative for
infectious agents, including Mycoplasma. Howe-
ver, as previously highlighted, this does not rule
out low-level intrasynovial infection. The degree
of cellular infiltration in our patient’s synovial tis-
sue was higher than usually found in patients with
aseptic arthritis and PID, where the most common
pattern of histological abnormalities is synovial
hyperplasia and capillary proliferation with no ma-
jor lymphocytic or neutrophilic infiltrate, little or
no plasma cells and B cells, most of the T cells be-
ing CD8+ cells for which neither the inducing me-
chanism nor the target is known.31,32 This pattern
contrasts with the one of rheumatoid arthritis,
where the synovial infiltrate contains large num-
bers of CD4+ T cells and of B cells.33 Thus, histolo-
gical examination of the synovial membrane may
be a useful diagnostic tool in patients with synovi-
tis and hypogammaglobulinemia. In the case we
present it also allowed us to rule out the hypothe-
sis of pigmented villonodular synovitis. 
IV immunoglobulin replacement therapy has
been described as being promptly effective in ma-
ny cases of immune dysregulation-related arthri-
tis17,19,32 but has not been consistently effective for
the prevention and treatment of mycoplasmal
arthritis.34 An anti-inflammatory effect of the im-
munoglobulin may be responsible for the rapid re-
solution in some cases of immune dysregulation-
related arthritis (although IV immunoglobulin is
not usually given at immunomodulatory doses).
Reports of low efficacy of IV immunoglobulin in the
treatment and prevention of both immune dysre-
gulation-related arthritis and mycoplasmal arthri-
tis may be ascribable to inadequate doses of IV im-
munoglobulin34 and in the case of mycoplasmal
arthritis, also hypothetically related to low con-
tents of anti-Mycoplasma antibodies and IgA in the
infusion, but little is known about humoral immu-
ne responses to Mycoplasma infections. 
In the treatment of Mycoplasma arthritis, ma-
crolides, quinolones and, above all, tetracyclines
can be effective,35-37 perhaps not only via their
known anti-Mycoplasma activity, but also via im-
munomodulating effects;38 however, the potential
benefit of this immunomodulating effect in myco-
plasmal arthritis in patients with PID has not been
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evaluated to date; if necessary, antibiotic treatment
can be continued for a prolonged period of 2-6
months in these patients.19,27,39
Infectious arthritis usually occurs only in pa-
tients with profound hypogammaglobulinemia. In
practice, keeping the serum immunoglobulin level
above 8 g/L is usually highly effective in preventing
Mycoplasma infections34,40 and in the report by
Franz et al34 this level is advised as the minimum
IgG trough level. Because of the difficulty in ruling
out low-level intrasynovial infection, concomitant
oral or intravenous administration of antibiotics
effective against Mycoplasma has been recommen-
ded, even in patients with negative results from
cultures and Polimerase Chain Reaction assays of
synovial specimens.19 Because mycoplasmas are
the most common cause of arthritis in patients
with humoral PID, it has been recommended that
antibiotic treatment should not be delayed while
waiting for results of cultures.34 These strategies re-
main controversial.
An additional issue is that the diagnosis of Myco-
plasma/Ureaplasma infection may be missed be-
cause appropriate culture media or special techni-
ques are not used. This may have happened in our
patient. We believe that synovial fluid from affec-
ted joints in patients with PID should be prompt-
ly aspirated and cultured and that early suspicion
of a mycoplasmal infection is crucial to ensure that
appropriate culture media for mycoplasmas and
ureaplasmas are used, bearing in mind that certain
individual species need special culture conditions.
In fact, some mycoplasmal species may require
additional nonculture methods such as a polyme-
rase chain reaction assay,41 16S rRNA sequence
analysis,39 or DNA hybridization42 to identify the
particular organism. Cultures may need to be in-
cubated for a minimum of 6 weeks.
Our patient’s treatment plan aimed at the main-
tenance of high levels of serum immunoglobulin
(above 8g/L) during the arthritis flare. This appro-
ach was based on the reported efficacy of IV immu-
noglobulin in many cases of immune dysregula-
tion-related arthritis.17,19,32 Although no evidence of
Mycoplasma/Ureaplasma infection was found, this
approach was also based on published studies42,43
suggesting that, while mycoplasmal arthritis can
develop on inadequately dosed IV immunoglobu-
lin therapy, it can also be seen in patients on stan-
dard IV immunoglobulin.34,39,40,44,45 Higher immu-
noglobulin levels could presumably improve im-
mune regulation and also improve the immune
means of clearing occult synovial infection. Aiming
at levels of serum immunoglobulin above 8g/L as
a general measure/approach in XLA patients is fur-
ther supported by retrospective analyses of agam-
maglobulinemic children revealing that the num-
ber and severity of infectious complications is in-
versely correlated with the dose of IGIV adminis-
tered.46,47 In particular, when IgG trough levels were
maintained at greater than 8 g/L, serious bacterial
illness and enteroviral meningoencephalitis were
prevented.46 Further studies are needed to clarify
the cost-effectiveness of such strategy.
Arthritis at the age of 23 eventually resolved over
a few months and although it was not done we be-
lieve that a concomitant trial of tetracyclines would
have also been a well supported strategy at that time.
Such decision could be justified by the current evi-
dence for Mycoplasma/Ureaplasma as the main cau-
se of arthritis in patients with XLA and CVID and by
the difficulty in ruling out low-level intrasynovial in-
fection and culturing these organisms, which ham-
per the diagnosis of such infection.
In conclusion, we wish to highlight that among im-
munodeficiencies, arthritis occurs chiefly in humo-
ral PID, namely XLA or CVID, and may be one of the
warning signs for PID. It may be related to infection,
most notably by Mycoplasma, or immune dysfunc-
tion. In children and occasionally in young adults, a
combination of arthritis and hypogammaglobuline-
mia should suggest PID, although other causes of
hypogammaglobulinemia must be excluded. Physi-
cians evaluating patients with arthritis should be awa-
re of that fact so that an early diagnosis can be pursu-
ed, as it is of extreme importance in the optimal ma-
nagement and prognosis of patients with PID. Im-
munoglobulin replacement therapy should be
promptly started irrespective of the clinical phe-
notype, as soon as the diagnosis is established.
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